Tor Åge Myklebust - Concepedia

Author

Tor Åge Myklebust

Also Known As

Dr. Tor Myklebust, Myklebust, Tor, Myklebust, Tor Å., Myklebust, Tor Åge, T A Myklebust, T Å Myklebust, T. Myklebust, T. Å. Myklebust, T.-A. Myklebust, T.A. Myklebust

286

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Cancer Registry of Norway Ålesund Hospital Oslo University Hospital University of Oslo Norwegian University of Science and Technology

TÅ

About

Tor Åge Myklebust is an author at Cancer Registry of Norway specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.7K
2	Health Sciences	2	2	128
3	Business	1	1	27
4	Engineering	1	1	18
5	Nursing	1	1	55

Tor Åge Myklebust

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study Melina Arnold, Mark J. Rutherford, Aude Bardot, The Lancet Oncology EpidemiologyCancer EpidemiologyMedicineGlobal HealthCancer Survival	2019	1K
Transanal total mesorectal excision for rectal cancer has been suspended in Norway Hans H. Wasmuth, Arne E. Færden, Tor Åge Myklebust, British journal of surgery	2019	251
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson, The Lancet. Gastroenterology & hepatology Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicinePancreatic Surgery	2024	174
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations Hege Elvebakken, Aurel Perren, Jean‐Yves Scoazec, Neuroendocrinology GastroenterologyPathologySurgeryGliomaTumor Biology	2020	101
Cancer Risk in Women Treated with Fertility Drugs According to Parity Status—A Registry-based Cohort Study Marte Myhre Reigstad, Ritsa Storeng, Tor Åge Myklebust, Cancer Epidemiology Biomarkers & Prevention	2017	97
Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993–2010 Marianne G. Guren, Hartwig Kørner, F. Pfeffer, Acta Oncologica	2015	82
Lifestyle predictors of successful aging: A 20-year prospective HUNT study Ingunn Bosnes, Hans M. Nordahl, Eystein Stordal, PLoS ONE	2019	82
Aspirin As Secondary Prevention in Patients With Colorectal Cancer: An Unselected Population-Based Study Simer Jit Bains, Milada Mahic, Tor Åge Myklebust, Journal of Clinical Oncology	2016	75
Long-term Relative Survival after Diagnosis of Testicular Germ Cell Tumor Øivind Kvammen, Tor Åge Myklebust, Arne Solberg, Cancer Epidemiology Biomarkers & Prevention	2016	66
Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era Ragnhild Hellesnes, Øivind Kvammen, Tor Åge Myklebust, International Journal of Cancer	2019	63

Page 1